Microbiota and mucosal defense in IBD: an update

References

• Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1): 46–54.e42. quiz e30.
   PubMed Web of Science ®Google Scholar
• Kaplan GG, Ng SC. Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China. Lancet Gastroenterol Hepatol. 2016;1(4):307–316.
   PubMed Web of Science ®Google Scholar
• Piovani D, Danese S, Peyrin-Biroulet L, et al. Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses. Gastroenterology. 2019;157(3):647–659.e4.
   PubMedGoogle Scholar
• The International IBD Genetics Consortium, Momozawa Y, Dmitrieva J, Théâtre E, et al. IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes. Nat Commun. 2018;9(1):2427.
   PubMedGoogle Scholar
• Asakura H, Suzuki K, Kitahora T, et al. Is there a link between food and intestinal microbes and the occurrence of Crohn’s disease and ulcerative colitis? J Gastroenterol Hepatol. 2008;23(12):1794–1801.
   PubMed Web of Science ®Google Scholar
• Sender R, Fuchs S, Milo R. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell. 2016;164(3):337–340.
   PubMed Web of Science ®Google Scholar
• Antoni L. Intestinal barrier in inflammatory bowel disease. World J Gastroenterol. 2014;20(5):1165.
   PubMed Web of Science ®Google Scholar
• Sartor RB, Wu GD. Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches. Gastroenterology. 2017;152(2):327–339.e4.
   PubMed Web of Science ®Google Scholar
• Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134(2):577–594.
   PubMed Web of Science ®Google Scholar
• Hildebrand H, Malmborg P, Askling J, et al. Early-life exposures associated with antibiotic use and risk of subsequent Crohn’s disease. Scand J Gastroenterol. 2008;43(8):961–966.
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn’s disease in the neoterminal ileum. Lancet. 1991;338(8770):771–774.
   PubMed Web of Science ®Google Scholar
• Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol. 1995;102(3):448–455.
   PubMed Web of Science ®Google Scholar
• Duchmann R, May E, Heike M, et al. T cell specificity and cross reactivity towards enterobacteria, Bacteroides, Bifidobacterium, and antigens from resident intestinal flora in humans. Gut. 1999;44(6):812–818.
   PubMed Web of Science ®Google Scholar
• Furrie E. Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn’s disease differentially activate the innate immune response. Gut. 2004;53(1):91–98.
   PubMed Web of Science ®Google Scholar
• Curciarello R, Canziani KE, Docena GH, et al. Contribution of non-immune cells to activation and modulation of the intestinal inflammation. Front Immunol. 2019;10:647.
   PubMed Web of Science ®Google Scholar
• Rubio CA, Schmidt PT. Severe defects in the macrophage barrier to gut microflora in inflammatory bowel disease and Colon Cancer. Anticancer Res. 2018;38(7):3811–3815.
   PubMed Web of Science ®Google Scholar
• Buttó LF, Haller D. Dysbiosis in intestinal inflammation: cause or consequence. Int J Med Microbiol. 2016;306(5):302–309.
   PubMed Web of Science ®Google Scholar
• Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016;65(2):330–339.
   PubMed Web of Science ®Google Scholar
• Dalal SR, Chang EB. The microbial basis of inflammatory bowel diseases. J Clin Invest. 2014;124(10):4190–4196.
   PubMed Web of Science ®Google Scholar
• McIlroy J, Ianiro G, Mukhopadhya I, et al. Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management. Aliment Pharmacol Ther. 2018;47(1):26–42.
   PubMed Web of Science ®Google Scholar
• Richard ML, Sokol H. The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases. Nat Rev Gastroenterol Hepatol. 2019;16(6):331–345.
   PubMed Web of Science ®Google Scholar
• Norman JM, Handley S, Baldridge M, et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell. 2015;160(3):447–460.
   PubMed Web of Science ®Google Scholar
• MetaHIT Consortium, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65.
   PubMed Web of Science ®Google Scholar
• The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–214.
   PubMed Web of Science ®Google Scholar
• Falony G, Joossens M, Vieira-Silva S, et al. Population-level analysis of gut microbiome variation. Science. 2016;352(6285):560–564.
   PubMed Web of Science ®Google Scholar
• Almeida A, Mitchell AL, Boland M, et al. A new genomic blueprint of the human gut microbiota. Nature. 2019;568(7753):499–504.
   PubMed Web of Science ®Google Scholar
• Vandeputte D, Kathagen G, D'hoe K, et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature. 2017;551(7681):507–511.
   PubMed Web of Science ®Google Scholar
• Franzosa EA, Morgan XC, Segata N, et al. Relating the metatranscriptome and metagenome of the human gut. Proc Natl Acad Sci. 2014;111(22):E2329–38.
   PubMed Web of Science ®Google Scholar
• Hollister EB, Riehle K, Luna RA, et al. Structure and function of the healthy pre-adolescent pediatric gut microbiome. Microbiome. 2015;3(1):36.
   PubMedGoogle Scholar
• Tropini C, Earle KA, Huang KC, et al. The Gut Microbiome: connecting spatial organization to function. Cell Host Microbe. 2017;21(4):433–442.
   PubMed Web of Science ®Google Scholar
• Manichanh C. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut. 2006;55(2):205–211.
   PubMed Web of Science ®Google Scholar
• Halfvarson J, Brislawn CJ, Lamendella R, et al. Dynamics of the human gut microbiome in inflammatory bowel disease. Nat Microbiol. 2017;2:17004.
   PubMed Web of Science ®Google Scholar
• Gevers D, Kugathasan S, Denson L, et al. The treatment-naive microbiome in new-Onset Crohn’s Disease. Cell Host Microbe. 2014;15(3):382–392.
   PubMed Web of Science ®Google Scholar
• Vandeputte D, Falony G, Vieira-Silva S, et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut. 2016;65(1):57–62.
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122(1):44–54.
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Weber J, Loening-Baucke V, et al. Spatial organization and composition of the Mucosal Flora in patients with Inflammatory Bowel Disease. J Clin Microbiol. 2005;43(7):3380–3389.
   PubMed Web of Science ®Google Scholar
• Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 2010;107(27):12204–12209.
   PubMed Web of Science ®Google Scholar
• Ott SJ. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004;53(5):685–693.
   PubMed Web of Science ®Google Scholar
• Frank DN, Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci. 2007;104(34):13780–13785.
   PubMed Web of Science ®Google Scholar
• Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology. 2004;127(2):412–421.
   PubMed Web of Science ®Google Scholar
• Lapaquette P, Glasser A-L, Huett A, et al. Crohn’s disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol. 2010;12(1):99–113.
   PubMed Web of Science ®Google Scholar
• Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008;105(43):16731–16737.
   PubMed Web of Science ®Google Scholar
• Huttenhower C, Kostic AD, Xavier RJ. Inflammatory Bowel Disease as a model for translating the Microbiome. Immunity. 2014;40(6):843–854.
   PubMed Web of Science ®Google Scholar
• Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, et al. Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease – associations with disease phenotype, treatment, and outcome. Clin Exp Gastroenterol. 2019;12:37–49.
   PubMed Web of Science ®Google Scholar
• Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60.
   PubMed Web of Science ®Google Scholar
• Forbes JD, Chen CY, Knox NC, et al. A comparative study of the gut microbiota in immune-mediated inflammatory diseases—does a common dysbiosis exist? Microbiome. 2018;6(1):221.
   PubMed Web of Science ®Google Scholar
• Lewis JD, Chen E, Baldassano R, et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn’s Disease. Cell Host Microbe. 2015;18(4):489–500.
   PubMed Web of Science ®Google Scholar
• Wills ES, Jonkers DMAE, Savelkoul PH, et al. Fecal microbial composition of ulcerative Colitis and Crohn’s Disease patients in remission and subsequent exacerbation. PLoS ONE. 2014;9(3):e90981.
   PubMed Web of Science ®Google Scholar
• Rajca S, Grondin V, Louis E, et al. Alterations in the intestinal microbiome (Dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohnʼs Disease. Inflamm Bowel Dis. 2014;20(6):978–986.
   PubMed Web of Science ®Google Scholar
• Braun T, Di Segni A, BenShoshan M, et al. Individualized dynamics in the gut microbiota precede Crohnʼs Disease Flares:. Am J Gastroenterol. 2019;114(7):1142–1151.
   Web of Science ®Google Scholar
• Wright EK, Kamm MA, Wagner J, et al. Microbial factors associated with postoperative Crohn’s Disease Recurrence. J Crohns Colitis. 2017;11(2):191–203.
   PubMed Web of Science ®Google Scholar
• Swiss IBD Cohort Investigators, Yilmaz B, Juillerat P, Øyås O, et al. Microbial network disturbances in relapsing refractory Crohn’s disease. Nat Med. 2019;25(2):323–336.
   PubMed Web of Science ®Google Scholar
• Kiely CJ, Pavli P, O’Brien CL. The role of inflammation in temporal shifts in the inflammatory bowel disease mucosal microbiome. Gut Microbes. 2018;1–9.
   Web of Science ®Google Scholar
• Vasquez N, Mangin I, Lepage P, et al. Patchy distribution of mucosal lesions in ileal Crohnʼs disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis. Inflamm Bowel Dis. 2007;13(6):684–692.
   PubMed Web of Science ®Google Scholar
• Libertucci J, Dutta U, Kaur S, et al. Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn’s disease. Am J Physiol-Gastrointest Liver Physiol. 2018;315(3):G420–31.
   PubMed Web of Science ®Google Scholar
• Hildebrand F, Nguyen TLA, Brinkman B, et al. Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice. Genome Biol. 2013;14(1):R4.
   PubMed Web of Science ®Google Scholar
• Craven M, Egan CE, Dowd SE, et al. Inflammation drives dysbiosis and bacterial invasion in murine models of Ileal Crohn’s Disease. PLoS ONE. 2012;7(7):e41594.
   PubMed Web of Science ®Google Scholar
• MetaHIT Consortium (additional members), et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174–180.
   PubMed Web of Science ®Google Scholar
• Knights D, Clare S, Goulding D, et al. Rethinking ‘Enterotypes,’. Cell Host Microbe. 2014;16(4):433–437.
   PubMed Web of Science ®Google Scholar
• Lepage P, Häsler R, Spehlmann ME, et al. Twin study indicates loss of interaction between Microbiota and Mucosa of patients with Ulcerative Colitis. Gastroenterology. 2011;141(1):227–236.
   PubMed Web of Science ®Google Scholar
• Dicksved J, Halfvarson J, Rosenquist M, et al. Molecular analysis of the gut microbiota of identical twins with Crohn’s disease. Isme J. 2008;2(7):716–727.
   PubMed Web of Science ®Google Scholar
• Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139(6):1844–1854.e1.
   PubMed Web of Science ®Google Scholar
• Hedin CR, van der Gast CJ, Stagg AJ, et al. The gut microbiota of siblings offers insights into microbial pathogenesis of inflammatory bowel disease. Gut Microbes. 2017;8(4):359–365.
   PubMed Web of Science ®Google Scholar
• Joossens M, Huys G, Cnockaert M, et al. Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives. Gut. 2011;60(5):631–637.
   PubMed Web of Science ®Google Scholar
• Sidiq T, Yoshihama S, Downs I, et al. Nod2: a critical regulator of Ileal Microbiota and Crohn’s Disease. Front Immunol. 2016;7.
   PubMed Web of Science ®Google Scholar
• Petnicki-Ocwieja T, Hrncir T, Liu Y-J, et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci. 2009;106(37):15813–15818.
   PubMed Web of Science ®Google Scholar
• Knights D, Silverberg MS, Weersma RK, et al. Complex host genetics influence the microbiome in inflammatory bowel disease. Genome Med. 2014;6(12).
   PubMedGoogle Scholar
• Zhang T, DeSimone RA, Jiao X, et al. Host genes related to paneth cells and xenobiotic metabolism are associated with shifts in human Ileum-Associated Microbial Composition. PLoS ONE. 2012;7(6):e30044.
   PubMed Web of Science ®Google Scholar
• Li E, Zhang Y, Tian X, et al. Influence of Crohn’s disease related polymorphisms in innate immune function on ileal microbiome. Plos One. 2019;14(2):e0213108.
   PubMed Web of Science ®Google Scholar
• Häsler R, Sheibani-Tezerji R, Sinha A, et al. Uncoupling of mucosal gene regulation, mRNA splicing and adherent microbiota signatures in inflammatory bowel disease. Gut. 2017;66(12):2087–2097.
   PubMed Web of Science ®Google Scholar
• Imhann F, Vich Vila A, Bonder MJ, et al. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut. 2018;67(1):108–119.
   PubMed Web of Science ®Google Scholar
• Bonder MJ, Kurilshikov A, Tigchelaar EF, et al. The effect of host genetics on the gut microbiome. Nat Genet. 2016;48(11):1407–1412.
   PubMed Web of Science ®Google Scholar
• Kurilshikov A, Wijmenga C, Fu J, et al. Host genetics and Gut Microbiome: challenges and perspectives. Trends Immunol. 2017;38(9):633–647.
   PubMed Web of Science ®Google Scholar
• Blekhman R, Goodrich JK, Huang K, et al. Host genetic variation impacts microbiome composition across human body sites. Genome Biol. 2015;16(1):191.
   PubMed Web of Science ®Google Scholar
• Rapozo DCM, Bernardazzi C, de Souza HSP. Diet and microbiota in inflammatory bowel disease: the gut in disharmony. World J Gastroenterol. 2017;23(12):2124.
   PubMed Web of Science ®Google Scholar
• Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334(6052):105–108.
   PubMed Web of Science ®Google Scholar
• David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–563.
   PubMed Web of Science ®Google Scholar
• Chiba M. Westernized diet is the most ubiquitous environmental factor in inflammatory Bowel Disease. Perm J. 2019;23:18–107.
   Google Scholar
• Kau AL, Ahern PP, Griffin NW, et al. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474(7351):327–336.
   PubMed Web of Science ®Google Scholar
• Prideaux L, Kang S, Wagner J, et al. Impact of ethnicity, geography, and disease on the microbiota in health and Inflammatory Bowel Disease. Inflamm Bowel Dis. 2013;19(13):2906–2918.
   PubMed Web of Science ®Google Scholar
• Fischer M, Bittar M, Papa E, et al. Can you cause inflammatory bowel disease with fecal transplantation? A 31-patient case-series of fecal transplantation using stool from a donor who later developed Crohn’s disease. Gut Microbes. 2017;8(3):205–207.
   PubMed Web of Science ®Google Scholar
• Couturier-Maillard A, Secher T, Rehman A, et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest. 2013;123(2):700–711.
   PubMed Web of Science ®Google Scholar
• Schaubeck M, Clavel T, Calasan J, et al. Dysbiotic gut microbiota causes transmissible Crohn’s disease-like ileitis independent of failure in antimicrobial defence. Gut. 2016;65(2):225–237.
   PubMed Web of Science ®Google Scholar
• Al Nabhani Z, Lepage P, Mauny P, et al. Nod2 deficiency leads to a specific and transmissible mucosa-associated microbial dysbiosis which is independent of the mucosal barrier defect. J Crohn’s Colitis. 2016;10(12):1428–1436.
   Google Scholar
• Nakamoto N, Sasaki N, Aoki R, et al. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat Microbiol. 2019;4(3):492–503.
   PubMed Web of Science ®Google Scholar
• Rossen NG, Fuentes S, van der Spek MJ, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology. 2015;149(1):110–118.e4.
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149(1):102–109.e6.
   PubMed Web of Science ®Google Scholar
• Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017;389(10075):1218–1228.
   PubMed Web of Science ®Google Scholar
• Vermeire S, Joossens M, Verbeke K, et al. Donor species richness determines faecal microbiota transplantation success in inflammatory Bowel Disease. J Crohns Colitis. 2016;10(4):387–394.
   PubMed Web of Science ®Google Scholar
• Kump P, Wurm P, Gröchenig HP, et al. The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis. Aliment Pharmacol Ther. 2018;47(1):67–77.
   PubMed Web of Science ®Google Scholar
• Ott SJ, Waetzig GH, Rehman A, et al. Efficacy of sterile fecal filtrate transfer for treating patients with clostridium difficile infection. Gastroenterology. 2017;152(4):799–811.e7.
   PubMed Web of Science ®Google Scholar
• Kruis W, Fric P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut. 2004;53(11):1617–1623.
   PubMed Web of Science ®Google Scholar
• Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415(6870):389–395.
   PubMed Web of Science ®Google Scholar
• Ostaff MJ, Stange EF, Wehkamp J. Antimicrobial peptides and gut microbiota in homeostasis and pathology: homeostasis in the gut. EMBO Mol Med. 2013;5(10):1465–1483.
   PubMed Web of Science ®Google Scholar
• Schauber J, Rieger D, Weiler F, et al. Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases. Eur J Gastroenterol Hepatol. 2006;18(6):615–621.
   PubMed Web of Science ®Google Scholar
• Küchler R, Schroeder BO, Jaeger SU, et al. Antimicrobial activity of High-Mobility-Group Box 2: a new function to a well-known protein. Antimicrob Agents Chemother. 2013;57(10):4782–4793.
   PubMed Web of Science ®Google Scholar
• Antoni L, Nuding S, Weller D, et al. Human colonic mucus is a reservoir for antimicrobial peptides. J Crohns Colitis. 2013;7(12):e652–664.
   PubMedGoogle Scholar
• Chu H, Pazgier M, Jung G, et al. Human α-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets,”. Science. 2012;337(6093):477–481.
   PubMed Web of Science ®Google Scholar
• Raschig J, Mailänder-Sánchez D, Berscheid A, et al. Ubiquitously expressed Human Beta Defensin 1 (hBD1) forms bacteria-entrapping nets in a redox dependent mode of action. PLoS Pathog. 2017;13(3):e1006261.
   PubMed Web of Science ®Google Scholar
• Schroeder BO, Wu Z, Nuding S, et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1. Nature. 2011;469(7330):419–423.
   PubMed Web of Science ®Google Scholar
• Schroeder BO, Ehmann D, Precht JC, et al. Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide. Mucosal Immunol. 2015;8(3):661–671.
   PubMed Web of Science ®Google Scholar
• Wendler J, Ehmann D, Courth L, et al. Bacterial periplasmic oxidoreductases control the activity of oxidized human antimicrobial β-Defensin 1. Infect Immun. 2018;86(4):e00875–17.
   PubMed Web of Science ®Google Scholar
• Ehmann D, Wendler J, Koeninger L, et al. Paneth cell α-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments. Proc Natl Acad Sci. 2019;116(9):3746–3751.
   PubMed Web of Science ®Google Scholar
• Salzman NH, Hung K, Haribhai D, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol. 2010;11(1):76–83.
   PubMed Web of Science ®Google Scholar
• Cleynen I, Boucher G, Jostins L, et al. Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study. Lancet. 2016;387(10014):156–167.
   PubMed Web of Science ®Google Scholar
• Ogura Y, Lala S, Xin W, et al. Expression of NOD2 in Paneth cells: a possible link to Crohn’s ileitis. Gut. 2003;52(11):1591–1597.
   PubMed Web of Science ®Google Scholar
• Wehkamp J. NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal -defensin expression. Gut. 2004;53(11):1658–1664.
   PubMed Web of Science ®Google Scholar
• Wehkamp J, Salzman NH, Porter E, et al. Reduced Paneth cell alpha-defensins in ileal Crohn’s disease. Proc Natl Acad Sci U S A. 2005;102(50):18129–18134.
   PubMed Web of Science ®Google Scholar
• Simms LA, Doecke JD, Walsh MD, et al. Reduced -defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn’s disease. Gut. 2008;57(7):903–910.
   PubMed Web of Science ®Google Scholar
• Perminow G, Beisner J, Koslowski M, et al. Defective Paneth Cell—mediated host defense in pediatric Ileal Crohnʼs Disease. Am J Gastroenterol. 2010;105(2):452–459.
   PubMed Web of Science ®Google Scholar
• Haberman Y, Schirmer M, Dexheimer PJ, et al. Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis. Mucosal Immunol. 2019;12(2):491–502.
   PubMed Web of Science ®Google Scholar
• Tanabe H, Ayabe T, Maemoto A, et al. Denatured human alpha-defensin attenuates the bactericidal activity and the stability against enzymatic digestion. Biochem Biophys Res Commun. 2007;358(1):349–355.
   PubMed Web of Science ®Google Scholar
• Liu T-C, Naito T, Liu Z, et al. LRRK2 but not ATG16L1 is associated with Paneth cell defect in Japanese Crohn’s disease patients. JCI Insight. 2017;2(6):e91917.
   Web of Science ®Google Scholar
• VanDussen KL, Liu T-C, Li D, et al. Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn’s Disease. Gastroenterology. 2014;146(1):200–209.
   PubMed Web of Science ®Google Scholar
• Thachil E, Hugot J-P, Arbeille B, et al. Abnormal activation of autophagy-induced crinophagy in paneth cells from patients with Crohn’s Disease. Gastroenterology. 2012;142(5):1097–1099.e4.
   PubMed Web of Science ®Google Scholar
• Liu T-C, Gurram B, Baldridge MT, et al. Paneth cell defects in Crohn’s disease patients promote dysbiosis. JCI Insight. 2016;1(8).
   Web of Science ®Google Scholar
• Liu T-C, Kern JT, VanDussen KL, et al. Interaction between smoking and ATG16L1T300A triggers Paneth cell defects in Crohn’s disease. J Clin Invest. 2018;128(11):5110–5122.
   PubMed Web of Science ®Google Scholar
• Stappenbeck TS, McGovern DPB. Paneth Cell Alterations in the Development and Phenotype of Crohn’s Disease. Gastroenterology. 2017;152(2):322–326.
   PubMed Web of Science ®Google Scholar
• Tschurtschenthaler M, Adolph TE, Ashcroft JW, et al. Defective ATG16L1-mediated removal of IRE1α drives Crohn’s disease–like ileitis. J Exp Med. 2017;214(2):401–422.
   PubMed Web of Science ®Google Scholar
• Armbruster NS, Stange EF, Wehkamp J. In the Wnt of paneth cells: immune-epithelial crosstalk in small intestinal Crohn’s Disease. Front Immunol. 2017;8:1204.
   PubMed Web of Science ®Google Scholar
• Courth LF, Ostaff MJ, Mailänder-Sánchez D, et al. Crohn’s disease-derived monocytes fail to induce Paneth cell defensins. Proc Natl Acad Sci. 2015;112(45):14000–14005.
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Beisner J, Wang G, et al. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci U S A. 2010;107(19):8772–8777.
   PubMed Web of Science ®Google Scholar
• Wehkamp J, Harder J, Weichenthal M, et al. Inducible and constitutive beta-defensins are differentially expressed in Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2003;9(4):215–223.
   PubMed Web of Science ®Google Scholar
• Nuding S, Fellermann K, Wehkamp J, et al. Reduced mucosal antimicrobial activity in Crohn’s disease of the colon. Gut. 2007;56(9):1240–1247.
   PubMed Web of Science ®Google Scholar
• Campbell Y, Fantacone ML, Gombart AF. Regulation of antimicrobial peptide gene expression by nutrients and by-products of microbial metabolism. Eur J Nutr. 2012;51(8):899–907.
   PubMed Web of Science ®Google Scholar
• Cobo ER, Kissoon-Singh V, Moreau F, et al. Colonic MUC2 mucin regulates the expression and antimicrobial activity of β-defensin 2. Mucosal Immunol. 2015;8(6):1360–1372.
   PubMed Web of Science ®Google Scholar
• Rubio CA. The natural antimicrobial enzyme lysozyme is up-regulated in gastrointestinal inflammatory conditions. Pathog Basel Switz. 2014;3(1):73–92.
   Google Scholar
• Magnusson MK, Strid H, Isaksson S, et al. The mucosal antibacterial response profile and fecal microbiota composition are linked to the disease course in patients with newly diagnosed ulcerative colitis. Inflamm Bowel Dis. 2017;23(6):956–966.
   PubMed Web of Science ®Google Scholar
• Wehkamp J, Stange EF. Paneth’s disease. J Crohns Colitis. 2010;4(5):523–531.
   PubMed Web of Science ®Google Scholar
• Allen A, Hutton DA, Pearson JP. The MUC2 gene product: a human intestinal mucin. Int J Biochem Cell Biol. 1998;30(7):797–801.
   PubMed Web of Science ®Google Scholar
• Axelsson MAB, Asker N, Hansson GC. O-Glycosylated MUC2 Monomer and Dimer from LS 174T Cells Are Water-soluble, whereas Larger MUC2 species formed early during biosynthesis are insoluble and contain nonreducible intermolecular bonds. J Biol Chem. 1998;273(30):18864–18870.
   PubMed Web of Science ®Google Scholar
• Asker N, Axelsson MAB, Olofsson S-O, et al. Dimerization of the human MUC2 mucin in the endoplasmic reticulum is followed by a N-Glycosylation-dependent transfer of the Mono- and Dimers to the Golgi Apparatus. J Biol Chem. 1998;273(30):18857–18863.
   PubMed Web of Science ®Google Scholar
• Godl K, Johansson MEV, Lidell ME, et al. The N Terminus of the MUC2 mucin forms trimers that are held together within a Trypsin-resistant core fragment. J Biol Chem. 2002;277(49):47248–47256.
   PubMed Web of Science ®Google Scholar
• Ambort D, Johansson MEV, Gustafsson JK, et al. Calcium and pH-dependent packing and release of the gel-forming MUC2 mucin. Proc Natl Acad Sci. 2012;109(15):5645–5650.
   PubMed Web of Science ®Google Scholar
• Wlodarska M, Thaiss C, Nowarski R, et al. NLRP6 Inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell. 2014;156(5):1045–1059.
   PubMed Web of Science ®Google Scholar
• Knoop KA, McDonald KG, McCrate S, et al. Microbial sensing by goblet cells controls immune surveillance of luminal antigens in the colon. Mucosal Immunol. 2015;8(1):198–210.
   PubMed Web of Science ®Google Scholar
• Birchenough GMH, Nyström EEL, Johansson MEV, et al. A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion. Science. 2016;352(6293):1535–1542.
   PubMed Web of Science ®Google Scholar
• Johansson MEV, Thomsson KA, Hansson GC. Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 Mucin, is strongly bound to the Fcgbp protein. J Proteome Res. 2009;8(7):3549–3557.
   PubMed Web of Science ®Google Scholar
• McGuckin MA, Lindén SK, Sutton P, et al. Mucin dynamics and enteric pathogens. Nat Rev Microbiol. 2011;9(4):265–278.
   PubMed Web of Science ®Google Scholar
• Meldrum OW, Yakubov GE, Bonilla MR, et al. Mucin gel assembly is controlled by a collective action of non-mucin proteins, disulfide bridges, Ca 2+ -mediated links, and hydrogen bonding. Sci Rep. 2018;8(1):5802.
   PubMedGoogle Scholar
• Nowarski R, Jackson R, Gagliani N, et al. Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis. Cell. 2015;163(6):1444–1456.
   PubMed Web of Science ®Google Scholar
• Ermund A, Schütte A, Johansson MEV, et al. Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer’s patches. Am J Physiol-Gastrointest Liver Physiol. 2013;305(5):G341–7.
   PubMed Web of Science ®Google Scholar
• Johansson MEV, Jakobsson H, Holmén-Larsson J, et al. Normalization of Host Intestinal Mucus Layers Requires Long-Term Microbial Colonization. Cell Host Microbe. 2015;18(5):582–592.
   PubMed Web of Science ®Google Scholar
• Schütte A, Ermund A, Becker-Pauly C, et al. Microbial-induced meprin β cleavage in MUC2 mucin and a functional CFTR channel are required to release anchored small intestinal mucus. Proc Natl Acad Sci. 2014;111(34):12396–12401.
   PubMed Web of Science ®Google Scholar
• Johansson MEV, Phillipson M, Petersson J, et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci. 2008;105(39):15064–15069.
   PubMed Web of Science ®Google Scholar
• Nyström EEL, Birchenough GMH, van der Post S, et al. Calcium-activated chloride channel regulator 1 (CLCA1) controls mucus expansion in colon by proteolytic activity. EBioMedicine. 2018;33:134–143.
   PubMed Web of Science ®Google Scholar
• Gustafsson JK, Ermund A, Johansson MEV, et al. An ex vivo method for studying mucus formation, properties, and thickness in human colonic biopsies and mouse small and large intestinal explants. Am J Physiol-Gastrointest Liver Physiol. 2011;302(4):G430–8.
   PubMed Web of Science ®Google Scholar
• Arike L, Holmén-Larsson J, Hansson GC. Intestinal Muc2 mucin O-glycosylation is affected by microbiota and regulated by differential expression of glycosyltranferases. Glycobiology. 2017;27(4):318–328.
   PubMed Web of Science ®Google Scholar
• Jakobsson HE, Rodríguez‐Piñeiro AM, Schütte A, et al. The composition of the gut microbiota shapes the colon mucus barrier. EMBO Rep. 2015;16(2):164–177.
   PubMed Web of Science ®Google Scholar
• Meyer-Hoffert U, Hornef MW, Henriques-Normark B, et al. Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut. 2008;57(6):764–771.
   PubMed Web of Science ®Google Scholar
• Okumura R, Kurakawa T, Nakano T, et al. Lypd8 promotes the segregation of flagellated microbiota and colonic epithelia. Nature. 2016;532(7597):117–121.
   PubMed Web of Science ®Google Scholar
• Troge A, Scheppach W, Schroeder BO, et al. More than a marine propeller – the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus. Int J Med Microbiol. 2012;302(7):304–314.
   PubMed Web of Science ®Google Scholar
• Bergström JH, Birchenough GMH, Katona G, et al. Gram-positive bacteria are held at a distance in the colon mucus by the lectin-like protein ZG16. Proc Natl Acad Sci. 2016;113(48):13833–13838.
   PubMed Web of Science ®Google Scholar
• Fritsch J, Abreu MT. The Microbiota and the Immune Response: what Is the Chicken and What Is the Egg? Gastrointest Endosc Clin N Am. 2019;29(3):381–393.
   PubMedGoogle Scholar
• van der Post S, Jabbar KS, Birchenough G, et al. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis. Gut. Published Online First: 26 March 2019. doi: 10.1136/gutjnl-2018-317571.
   PubMed Web of Science ®Google Scholar
• Schirmer M, Denson L, Vlamakis H, et al. Compositional and temporal changes in the gut microbiome of pediatric ulcerative colitis patients are linked to disease course. Cell Host Microbe. 2018;24(4):600–610.e4.
   PubMed Web of Science ®Google Scholar
• Haberman Y, Karns R, Dexheimer PJ, et al. Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response. Nat Commun. 2019;10(1):38.
   PubMedGoogle Scholar
• Johansson MEV, Gustafsson JK, Holmén-Larsson J, et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut. 2014;63(2):281–291.
   PubMed Web of Science ®Google Scholar
• Schroeder BO, Birchenough GMH, Ståhlman M, et al. Bifidobacteria or fiber protects against diet-induced microbiota-mediated colonic mucus deterioration. Cell Host Microbe. 2018;23(1):27–40.e7.
   PubMed Web of Science ®Google Scholar
• Desai MS, Seekatz AM, Koropatkin NM, et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016;167(5):1339–1353.e21.
   PubMed Web of Science ®Google Scholar
• Martens EC, Chiang HC, Gordon JI. Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe. 2008;4(5):447–457.
   PubMed Web of Science ®Google Scholar
• Abrham G, Volpe M, Shpungin S, et al. TMF/ARA160 downregulates proangiogenic genes and attenuates the progression of PC3 xenografts. Int J Cancer. 2009;125(1):43–53.
   PubMed Web of Science ®Google Scholar
• Bel S, Elkis Y, Lerer-Goldstein T, et al. Loss of TMF/ARA160 protein renders colonic mucus refractory to bacterial colonization and diminishes intestinal susceptibility to Acute Colitis. J Biol Chem. 2012;287(30):25631–25639.
   PubMed Web of Science ®Google Scholar
• Bel S, Elkis Y, Elifantz H, et al. Reprogrammed and transmissible intestinal microbiota confer diminished susceptibility to induced colitis in TMF−/− mice. Proc Natl Acad Sci. 2014;111(13):4964–4969.
   PubMed Web of Science ®Google Scholar
• Martín R, Chamignon C, Mhedbi-Hajri N, et al. The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response. Sci Rep. 2019;9(1):5398.
   PubMedGoogle Scholar
• Ahl D, Liu H, Schreiber O, et al. Lactobacillus reuteri increases mucus thickness and ameliorates dextran sulphate sodium-induced colitis in mice. Acta Physiol. 2016;217(4):300–310.
   PubMed Web of Science ®Google Scholar
• Dicksved J, Schreiber O, Willing B, et al. Lactobacillus reuteri Maintains a Functional Mucosal Barrier during DSS Treatment Despite Mucus Layer Dysfunction,”. Plos One. 2012;7(9):e46399.
   PubMed Web of Science ®Google Scholar
• Wrzosek L, Miquel S, Noordine ML, et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 2013;11(1):61.
   PubMedGoogle Scholar
• Geirnaert A, Calatayud M, Grootaert C, et al. Butyrate-producing bacteria supplemented in vitro to Crohn’s disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity. Sci Rep. 2017;7(1):11450.
   PubMedGoogle Scholar
• Wlodarska M, Luo C, Kolde R, et al. Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation. Cell Host Microbe. 2017;22(1):25–37.e6.
   PubMed Web of Science ®Google Scholar
• Hutkins RW, Krumbeck JA, Bindels LB, et al. Prebiotics: why definitions matter. Curr Opin Biotechnol. 2016;37:1–7.
   PubMed Web of Science ®Google Scholar
• Hafer A, Krämer S, Duncker S, et al. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study. BMC Gastroenterol. 2007;7(1):36.
   PubMedGoogle Scholar
• Benjamin JL, Hedin CR, Koutsoumpas A, et al. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn’s disease. Gut. 2011;60(7):923–929.
   PubMed Web of Science ®Google Scholar
• Chermesh I, Tamir A, Reshef R, et al. Failure of Synbiotic 2000 to Prevent Postoperative Recurrence of Crohn’s Disease. Dig Dis Sci. 2007;52(2):385–389.
   PubMed Web of Science ®Google Scholar
• Fujimori S, Gudis K, Mitsui K, et al. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition. 2009;25(5):520–525.
   PubMed Web of Science ®Google Scholar
• Currò D, Ianiro G, Pecere S, et al. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. Br J Pharmacol. 2017;174(11):1426–1449.
   PubMed Web of Science ®Google Scholar
• Shin W, Kim HJ. Intestinal barrier dysfunction orchestrates the onset of inflammatory host–microbiome cross-talk in a human gut inflammation-on-a-chip. Proc Natl Acad Sci. 2018;115(45):E10539–47.
   PubMed Web of Science ®Google Scholar
• Wehkamp J, Harder J, Wehkamp K, et al. NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun. 2004;72(10):5750–5758.
   PubMed Web of Science ®Google Scholar
• Wendler J, Schroeder BO, Ehmann D, et al. Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide. Sci Rep. 2019;9(1):3640.
   PubMedGoogle Scholar
• Stremmel W, Merle U, Zahn A, et al. Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis. Gut. 2005;54(7):966–971.
   PubMed Web of Science ®Google Scholar
• Stremmel W, Staffer S, Gehrke S. The Detergent Effect of Mesalazine Interferes with Phosphatidylcholine Binding to Mucin 2. Inflamm Intest Dis. 2018;3(3):107–115.
   PubMedGoogle Scholar
• Becker S, Schott C, Wolff C, et al. Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo. PloS One. 2013;8(2):e55620.
   PubMed Web of Science ®Google Scholar
• Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut. 2004;53(1):1–4.
   PubMed Web of Science ®Google Scholar
• Zuo T, Kamm MA, Colombel J-F, et al. Urbanization and the gut microbiota in health and inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2018;15(7):440–452.
   Web of Science ®Google Scholar
• Hall AB, Yassour M, Sauk J, et al. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med. 2017;9(1):103.
   PubMedGoogle Scholar
• Ananthakrishnan AN, Luo C, Yajnik V, et al. Gut microbiome function predicts response to anti-integrin biologic therapy in Inflammatory Bowel Diseases. Cell Host Microbe. 2017;21(5):603–610.e3.
   PubMed Web of Science ®Google Scholar